Ad hoc announcement - Inside information pursuant to Article 17 MAR

Heidelberg Pharma AG Raises EUR 14.4 Million From Private Placement

Ladenburg, Germany, 27 April 2020 - Heidelberg Pharma AG (FSE: WL6) announces that it has successfully raised approximately EUR 14.4 million in gross proceeds through a private placement via an accelerated book building transaction. Heidelberg Pharma issued 2,820,961 new shares from authorized capital, which corresponds to approximately 10% of the current share capital. Of these, 2,679,961 shares were allocated to the main investor dievini Hopp Biotech holding GmbH & Co. KG, Walldorf, (dievini) as well as 141,000 shares to institutional investors at a price of EUR 5.10 per share, which represents a discount of approximately 5% to the daily closing price. The capital measure will increase the total number of registered shares after the issuance to 31,030,572.

The issuance of new shares was resolved today by the Management Board and Supervisory Board of Heidelberg Pharma AG. The new shares will be admitted to trading on the Frankfurt Stock Exchange after the capital increase has been entered in the commercial register.

The capital increase has been executed by MainFirst Bank AG, Kennedyallee 76, 60596 Frankfurt, Germany, acting as global coordinator and sole bookrunner.

Important notes
This ad hoc announcement does not constitute an offer to sell or a solicitation to buy securities. Specifically, this document does not constitute an offer to sell securities or the solicitation to submit an offer to buy securities in the United States of America, Canada, Japan and Australia. The shares of Heidelberg Pharma AG (the "Shares") may not be offered or sold in the United States of America or to or for the account or benefit of "U.S. persons" (as defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act")), unless they have been registered or are exempt from registration under the Securities Act. The shares have not been and will not be registered under the Securities Act. There will be no public offer of shares in the United States of America, Canada, Japan and Australia.

+++ End of the ad hoc announcement +++